Coronavirus: COVID-19
The Atlantic’s coverage of the coronavirus that causes COVID-19
The Atlantic’s coverage of the coronavirus that causes COVID-19
At some point—maybe even soon—the emergency phase of the pandemic will end. But what, exactly, is that magic threshold?
An uncertain spring, an amazing summer, a cautious fall and winter, and then, finally, relief.
In November, COVID-19 levels shot past the worst of the summer’s surge. Now they’re back below that threshold.
Why have the economic and psychological stresses of the pandemic hit women harder—and what can we do about it?
Families will gather. Restaurants will reopen. People will travel. The pandemic may feel like it’s behind us—even if it’s not.
Every major pandemic indicator has been falling for weeks.
Local health departments are counting on lifestyle bloggers and fitness experts to get their message out.
Vaccine regimens need both science and public trust to succeed.
Four reasons: social distancing, seasonality, seroprevalence, and shots.
Vaccines are a public good. Until the world regards them as such, the pandemic will not end.
The virus is evolving, but the antibodies that fight it can change, too.
Cases are down 57 percent from the country’s all-time peak in early January, according to the COVID Tracking Project.
Antibody tests can determine whether your immune system has seen the coronavirus before—and not much else.
Hitting the threshold might actually be impossible. But vaccines can still help end the pandemic.
The case count in the U.S. hadn’t dipped that low since November.
The Brazil variant raises a scary question—and reminds us that herd immunity matters across borders.
New COVID-19 cases, hospitalizations, and deaths all dropped this week.
This winter has been an extraordinarily quiet flu season. Scientists aren’t sure the silence will last.
Americans can plan for the pandemic’s end in the fall. What happens between now and then?
Side effects are just a sign that protection is kicking in as it should.